The meningitis outbreak

Globe coverage of the outbreak tied to steroid shots from a compounding pharmacy in Framingham, which has killed dozens and sickened hundreds.

About the meningitis outbreak

The deadly US outbreak of fungal meningitis, which has killed dozens and sickened hundreds, has been link to a steroid shots from a Framingham compounding pharmacy. The outbreak, which is likely to lead to a flood of lawsuits, has also led the state to revoke the license for the New England Compounding Center, and to step up surprise inspections at similar companies in the state.

Framingham compounding pharmacy

Federal agents secured the area outside the New England Compounding Center in 2012.

$135m deal proposed in compounding pharmacy bankruptcy case

At least $135 million could be available for claims in the deadly meningitis outbreak linked to a now-defunct Framingham pharmacy.

FBI probing meningitis outbreak linked to Mass. firm

Agents are interviewing Tennessee residents sickened or widowed by fungal meningitis as part of a criminal investigation.

Hearings and investigations

Glenn Adam Chin left court Thursday.

Pharmacist tied to outbreak a ‘scapegoat,’ lawyer says

Glenn Adam Chin was released on bond from charges related to the fungal meningitis outbreak that killed 64 people.

Oversight and regulations

New law increases oversight of compounding pharmacies

Compounding pharmacies came under scrutiny after a deadly meningitis outbreak was linked to a Framingham pharmacy in 2012.

$100m settlement reached over meningitis cases

The agreement with the Mass. compounding pharmacy linked to the fungal meningitis outbreak would pave the way for victims to be compensated.

Lawsuits

Globe Investigations

Special section

//c.o0bg.com/rf/image_90x90/Boston/2011-2020/2013/10/01/BostonGlobe.com/Special/Images/magnifying_glass1500618-081--90x90.jpg Recent investigative reports

Read recent stories and ongoing investigations from the Globe’s journalists.